top of page
Search

Histamine Test Kit Market, Global Outlook and Forecast 2025-2032

  • Writer: siddhesh kapshikar
    siddhesh kapshikar
  • 9 hours ago
  • 3 min read

According to a new report from Intel Market Research, the global Histamine Test Kit market was valued at USD 141 million in 2024 and is projected to reach USD 228 million by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032). This growth is driven by increasing food safety regulations, rising consumer health awareness, and technological advancements in diagnostic testing.

What is a Histamine Test Kit?

Histamine Test Kits are specialized diagnostic tools designed to measure histamine levels in various samples. Histamine, a biogenic amine, plays crucial roles in allergic responses and inflammatory processes but becomes hazardous when accumulated in food products like fish, cheese, and fermented items. These kits help detect histamine poisoning risks, which can cause symptoms ranging from mild allergic reactions to severe anaphylaxis.

The market offers multiple testing formats including ELISA (Enzyme-Linked Immunosorbent Assay) and LFIA (Lateral Flow Immunoassay) kits. PerkinElmer leads the industry with FDA-approved testing solutions, while European manufacturers like R-Biopharm and Romer Labs comply with stringent EU food safety standards.

Key Market Drivers

1. Strengthening Global Food Safety Regulations

Governments worldwide are implementing stricter food safety controls. The FDA's Hazard Analysis and Critical Control Points (HACCP) guidelines mandate histamine testing in seafood, while the European Commission Regulation (EC) No 2073/2005 sets maximum histamine levels at 200-400 mg/kg for fishery products. These regulations compel food producers to adopt reliable testing solutions, driving market growth.

2. Rising Consumer Demand for Food Safety

Increasing cases of histamine poisoning from contaminated tuna and mackerel have heightened consumer awareness. A 2022 study published in Food Control journal revealed that 78% of seafood-related foodborne illnesses in North America link to histamine contamination. This has accelerated adoption in food processing facilities and restaurants.

3. Technological Advancements in Testing

Recent innovations include:

  • Rapid LFIA tests delivering results in 15 minutes (vs traditional 2-hour ELISA tests)

  • Smartphone-integrated readers for portable quantification

  • Automated high-throughput systems for industrial applications

Market Challenges

Despite growth potential, the industry faces hurdles:

  • High costs of accredited laboratory-grade testing equipment

  • Varying regulatory standards across regions creating compliance complexities

  • Limited awareness among small-scale food producers in developing markets

Opportunities

Emerging trends present growth avenues:

  • Expansion in Asia-Pacific with Japan's tightened seafood export controls

  • Pharmaceutical applications for allergy diagnosis and mast cell disorder testing

  • Blockchain integration for test result traceability in supply chains

Regional Insights

  • North America (40% market share): Strict FDA regulations and seafood imports drive demand

  • Europe: Mature market with advanced testing infrastructure

  • Asia-Pacific: Fastest-growing region with expanding food processing sectors

Market Segmentation

By Specification

  • ELISA

  • LFIA

  • Others

By End User

  • Food & Beverage

  • Biological Research

  • Others

By Region

  • North America

  • Europe

  • Asia-Pacific

  • Latin America

  • Middle East & Africa

Competitive Landscape

The market is consolidated with key players including:

  • PerkinElmer (Market Leader)

  • Eurofins Scientific

  • Neogen Corporation

  • Thermo Fisher Scientific

  • R-Biopharm

About Intel Market Research

Intel Market Research is a leading provider of strategic intelligence, offering actionable insights in biotechnology, pharmaceuticals, and healthcare infrastructure. Our research capabilities include:

  • Real-time competitive benchmarking

  • Global clinical trial pipeline monitoring

  • Country-specific regulatory and pricing analysis

  • Over 500+ healthcare reports annually

Trusted by Fortune 500 companies, our insights empower decision-makers to drive innovation with confidence.

🌐 Website: https://www.intelmarketresearch.com📞 International: +1 (332) 2424 294📞 Asia-Pacific: +91 9169164321🔗 LinkedIn: Follow Us


VISIT MORE REPORT : 



 
 
 

Recent Posts

See All

Comments


bottom of page